Pleiotropic effects of rosuvastatin on the glucose metabolism and the subcutaneous and visceral adipose tissue behavior in C57Bl/6 mice

The aim of this study was to evaluate whether rosuvastatin (HMG-CoA reductase inhibitor) modulates the carbohydrate and lipid metabolism, the development of non-alcoholic fatty liver disease (NAFLD), and the increase in body mass in a model of diet-induced obesity. Male C57Bl/6 mice (3-months-old) w...

Descripción completa

Detalles Bibliográficos
Autores principales: Neto-Ferreira, Rodrigo, Rocha, Vinícius Novaes, Souza-Mello, Vanessa, Mandarim-de-Lacerda, Carlos Alberto, de Carvalho, Jorge José
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3716873/
https://www.ncbi.nlm.nih.gov/pubmed/23816341
http://dx.doi.org/10.1186/1758-5996-5-32

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3716873/
https://www.ncbi.nlm.nih.gov/pubmed/23816341
http://dx.doi.org/10.1186/1758-5996-5-32

Ejemplares similares